HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9

LifeMD, Inc.

LifeMD, Inc.

LFMD

0.00

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ: LFMD) with a Buy and lowers the price target from $10 to $9.